ALIVUS LIFE SCIENCES
Back to Cashflow Statement
|
ALIVUS LIFE SCIENCES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-6.23 Cr | ₹-279 Cr | ₹-388 Cr | ₹-79 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALIVUS LIFE SCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-64 Cr |
| Mar2025 | ₹-6.23 Cr |
| Mar2024 | ₹-279 Cr |
| Mar2023 | ₹-388 Cr |
| Mar2022 | ₹-79 Cr |
How is Cash Flow from Financing Activities of ALIVUS LIFE SCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-64 Cr | Negative | |
| Mar2025 | ₹-6.23 Cr | Negative | |
| Mar2024 | ₹-279 Cr | Negative | |
| Mar2023 | ₹-388 Cr | Negative | |
| Mar2022 | ₹-79 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹16,867.2 Cr | 3.4% | 17.6% | 43.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 3.4% |
17.6% |
43.2% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses